comparemela.com

Page 3 - Ingle Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AUD Meds at Discharge Dramatically Cuts Rehospitalization

Prescribing medication for alcohol use disorder on hospital discharge was associated with a significant decrease in the risk for an alcohol-related rehospitalization.

United statesEdeny bernsteinDepartment of medicineUniversity of torontoGeneral internal medicineMassachusetts general hospitalWid yaseenAlcohol useChronic diseaseChronic illnessClinical researchClinical trialsLinical studiesPre clinical trialDouble blind studyDouble blind studies

Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study

Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.

University of pennsylvaniaUnited statesMoonlake immunotherapeuticsBrian kirbyJoelm gelfandInternational hs severity score systemAmerican academy of dermatologyHidradenitis suppurativa clinical responsePrivate hospitalAmerican academyHurley stageScore systemDermatology life quality indexNumerical rating scaleGlobal impressionDisease severity

Ultraprocessed Food May Increase Long-Term Risk for IBS

Higher consumption of ultraprocessed food is tied to long-term risk of developing irritable bowel syndrome.

Shanshan wuCapital medical universityNational clinical research centerUnited kingdom biobankBeijing friendship hospitalDigestive diseaseClinical gastroenterologyIrritable bowel syndrome ibsAlignant neoplasiaAlignant neoplasmClinical researchClinical trialsLinical studiesPre clinical trialDouble blind studyDouble blind studies

Smartphone App Detects Early Signs of FTD

Cognitive assessments administered via a smartphone app proved accurate and reliable in detecting frontotemporal dementia in high-risk individuals.

Adamm staffaroniWalter kukullDatacubed healthNational alzheimer coordinating centerUniversity of california san franciscoUniversity of washingtonAging centerCalifornia san franciscoMedscape medicalMontreal cognitiveMedscape medical newsNational alzheimerCoordinating centerHealthcare and medical technologyEalth and medical techEalth and med tech

Review Describes Semaglutide-Associated Skin Effects

Alopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug.

Brown universityRhode islandUnited statesMeganm tranDrug administration medwatchWarren alpert medical schoolJournal of the american academy dermatologyDrug administrationAmerican academyAdverse effectsSide effectsBullous pemphigoidClinical researchClinical trialsLinical studiesPre clinical trial

vimarsana © 2020. All Rights Reserved.